Latest Breaking News On - Jeremias motte - Page 1 : vimarsana.com

Kyverna Therapeutics to attend the 2024 American Academy of Neurology (AAN) Annual Meeting in Denver, CO, With Data on KYV-101 in the Treatment of Patients with Neurological Autoimmune Diseases

/PRNewswire/ Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies.

United statesNordrhein westfalenPeter maagLily sarafanJeffrey dunnMarinos dalakasUniversity hospitalNational institutes of healthAmerican academy of neurologyExchange commissionThomas jefferson university hospitalsPrnewswire kyverna therapeutics incKyverna therapeutics incDepartment of neurologyAmerican academyJeremias motte

Kyverna Therapeutics To Attend The 2024 American Academy Of Neurology (AAN) Annual Meeting In Denver, CO, With Data On KYV-101 In The Treatment Of Pat

Kyverna Therapeutics To Attend The 2024 American Academy Of Neurology (AAN) Annual Meeting In Denver, CO, With Data On KYV-101 In The Treatment Of Pat
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesNordrhein westfalenPeter maagMarinos dalakasJeffrey dunnLily sarafanDepartment of neurologyAmerican academy of neurologyUniversity hospitalThomas jefferson university hospitalsNational institutes of healthPrnewswire kyverna therapeutics incKyverna therapeutics incExchange commissionAmerican academyJeremias motte